How To Help Kids Sleep Better
A study in the journal Archives of Disease in Childhood came to the following conclusion:…
A study in the journal Archives of Disease in Childhood came to the following conclusion:…
Are you at risk for heart disease? Use this calculator to find out.
An early stage clinical trial of the experimental drug dimebon (latrepirdine) in people with Huntington’s disease appears to be safe and may improve cognition. That is the conclusion of a study published in the Archives of Neurology.
A medication previously studied in patients with Alzheimer’s disease (latrepirdine) appears well tolerated and may improve thinking, learning and memory skills among individuals with Huntington’s disease, according to a report in the February issue of Archives of Neurology, one of the JAMA/Archives journals. “Huntington’s disease is a hereditary neurodegenerative disorder that affects movement …
A disease cluster scare implodes; a new one is born.